| Literature DB >> 34923989 |
Jianfei Pang1, Haifeng Xu1,2, Jun Ren2, Jun Yang2, Mei Li3, Dan Lu4, Dongsheng Zhao5.
Abstract
BACKGROUND: Acute care for critical illness requires very strict treatment timeliness. However, healthcare providers usually cannot accurately figure out the causes of low efficiency in acute care process due to the lack of effective tools. Besides, it is difficult to compare or conformance processes from different patient groups.Entities:
Keywords: Acute care; Ischemic stroke; Process mining; Quality improvement; Visual analysis
Mesh:
Year: 2021 PMID: 34923989 PMCID: PMC8684667 DOI: 10.1186/s12911-021-01725-1
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Fig. 1The process mining framework with time perspective
Fig. 2Classification and coding of clinical activities
The rules for preprocessing of patient data
| No | Rules | Comments |
|---|---|---|
| 1 | The patient's onset time and arrival time cannot be missing | Exact minute |
| 2 | The patient's onset time is earlier than the arrival time | |
| 3 | The start time of orders is later than patient's arrival time | |
| 4 | Patient's arrival time is earlier than the time arrival of neurology department | Applicable to cooperative hospitals |
| 5 | If the patient has more than one thrombolytic drug order, we will choose the earliest order to determine the start time of thrombolytic therapy | Thrombolytic drugs include rt-PA and urokinase |
| 6 | The time of arrival of neurology department will be determined by the first order issued after admission | |
| 7 | Range of rt-PA dosage: 20 mg ≤ n ≤ 300 mg | |
| 8 | Range of door-to-needle time: 0 < n ≤ 360 min | |
| 9 | Range of time from onset to start of thrombolytic therapy: 0 < n ≤ 360 min |
Overview of thrombosis and non-thrombosis cohort
| Characteristics | Intravenous thrombolysis (cohort = 125) | Non-thrombosis cohort (n = 295) |
|---|---|---|
| Mean (SD) age (years) | 65.5 (13.1) | 68.7 (13.3) |
| Men | 78 (62.4%) | 191 (64.7%) |
| Neurologic impairment* | ||
| 0 | 9 (7.2%) | 50 (16.9%) |
| 1 | 79 (63.2%) | 164 (55.6%) |
| 2 | 35 (28.0%) | 79 (26.8%) |
| 3 | 2 (1.6%) | 2 (0.7%) |
| Hours (SD) from stroke onset | 3.06 (0.90) | 4.3 (1.4) |
| Medical history | ||
| Stroke | 4 (3.2%) | 4 (1.4%) |
| Diabetes mellitus | 39 (31.2%) | 79 (26.8%) |
| Hypertension | 95 (76%) | 210 (71.2%) |
| Atrial fibrillation | 19 (15.2%) | 46 (15.6%) |
| Mean (SD) systolic blood Pressure (mm Hg) | 145.1 (23.3) | 143.1 (20.7) |
| Mean (SD) heart rate | 76.9 (11.5) | 78.9 (12.7) |
| Mean (SD) respiratory rate | 16.8 (1.8) | 17.1 (1.7) |
| Mean (SD) Temperature (℃) | 36.5 (0.3) | 36.4 (0.3) |
| Mean (SD) Glu (mmol/L) | 8.2 (3.6) | 7.9 (3.2) |
*Neurologic impairment contains “Facial asymmetry”, “Arm and leg weakness”, “Slurring of speech”, adding one score for each positive
Fig. 3Process model discovered: Thrombolytic cohort (A), Non-thrombolytic cohort (B)
KPIs for AIS
| KPIs | Case study result | Relevant researches result | Explanation |
|---|---|---|---|
| INT | 33 min | 31 min (RCSN in Canada) | Median |
| DNT | 117 min | 68 min (SITS-MOST) | Median |
| The proportion of patients with AIS received thrombolysis therapy within 60 min | 6.4% | Target 75% (Report on Stroke Prevention and Treatment in China 2018) | Patients received intravenous thrombolysis therapy within 60 min after arrival hospital |
| Thrombolysis rate of patients arrive at hospital within 2 h | 37.1% | 71.6% (GWTG 2009 in the United States) | Patients who arrived within 2 h after initial symptom onset and were treated within 3 h |